Oncology Drug Discovery Delivering Translational Excellence & Fulfilling the Promise of Individualized Care July 10, 2020 Devin Carty & Wes Chapman Translation: “the process of [...]
Read more
Category "Medical"
COVID-19; What is Angela Merkel telling us?
COVID-19; What is Angela Merkel telling us? “We have to understand that many people will be infected, … The consensus among [...]
Read more
An analysis of FDA oncology drug approvals – implications for patients and clinical trials
2018/2019 Oncology Drug FDA Approvals Notifications Implications for Early Phase Clinical Trials Dr. Wael Harb & Wes Chapman August 18, 2019 Illustration of an [...]
Read more
Medical Oncology Practice Valuation – Art & Science
Medical Oncology Practice Valuation Art and Science The Oncology Valuation Series November 27, 2018 Wes Chapman President & CEO of Verdi Oncology, Inc. “In the short [...]
Read more
EBITDA – The Oncology Valuation Series
EBITDA What is it, and why does it matter? The Oncology Valuation Series November 21, 2018 Wes Chapman President & CEO of Verdi Oncology, Inc. My [...]
Read more
240% Growth in Oncology Drug Approvals in 2017; Good News for Cancer Patients
240% Growth in Oncology Drug Approvals in 2017 Good News for Cancer Patients Wes Chapman January 2, 2018 Introduction Advances in medical oncology depend on [...]
Read more
MIPS for Medical Oncology Practices – Strategic Considerations
MIPS/MACRA 2018 Strategic Considerations for Medical Oncology Practices Implications of a Zero Sum Game Wes Chapman December 2017 A Doomsday Solution to a Zero Sum [...]
Read more
340B medical Oncology Practices and Hospitals – Time to Bail Out?
340B Medical Oncology Practices and Hospitals - Time to Bail Out? November 20, 2017 Wes Chapman Time to Bail Out of 340B? On November [...]
Read more
Silent Clues to Fixing Healthcare
Hey, President Trump, To fix the Healthcare mess, listen to the dog that didn’t bark! Dr. Grant Bagley & Wes Chapman July 4, [...]
Read more
Private Payers – Use Artificial Intelligence to Reduce Costs, Improve Care and End Prior Authorization
Practical Applications of Artificial Intelligence in Oncology Care Part II: Private Payers Using the OCM Infrastructure and AI: Wes Chapman February 7, 2016 Occam’s [...]
Read more